EntryPoint Capital’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
10,184
+4,736
+87% +$446K 0.18% 167
2026
Q1
$644K Sell
5,448
-3,666
-40% -$453K 0.19% 168
2025
Q4
$1.15M Buy
9,114
+4,275
+88% +$558K 0.45% 10
2025
Q3
$708K Buy
+4,839
New +$731K 0.27% 71
2024
Q3
Sell
-1,273
Closed -$221K 1442
2024
Q2
$221K Sell
1,273
-423
-25% -$70.4K 0.1% 351
2024
Q1
$287K Buy
1,696
+1,695
+169,500% +$317K 0.26% 34
2023
Q4
$197 Buy
+1
New +$177 ﹤0.01% 1305

Other funds holding ZTS

EntryPoint Capital's ZTS Position: Q2 2026 in Review

EntryPoint Capital increased its Zoetis (ZTS) stake by 87% in Q2 2026, buying an estimated $446K and bringing the position to 10,184 shares worth $732K. The position accounts for 0.18% of the portfolio, ranked #167.

EntryPoint Capital first reported a position in ZTS in Q4 2023 and has held it in 7 quarters since. The position peaked at $1.15M in Q4 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • EntryPoint Capital held 10,184 shares of Zoetis worth $732K as of Q2 2026.
  • EntryPoint Capital bought 4,736 Zoetis shares in Q2 2026, an estimated $446K.
  • Zoetis made up 0.18% of EntryPoint Capital's portfolio in Q2 2026, its #167 holding.
  • EntryPoint Capital first reported a position in Zoetis in Q4 2023 and has held it in 7 quarters since.
  • EntryPoint Capital's Zoetis position peaked at $1.15M in Q4 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.